Logo

Orange Book: Approved Drug Products with Therapeutic Equivalence

Small book cover: Orange Book: Approved Drug Products with Therapeutic Equivalence

Orange Book: Approved Drug Products with Therapeutic Equivalence

Publisher: U.S. Department of Health and Human Services
Number of pages: 1252

Description:
The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).

Home page url

Download or read it online for free here:
Download link
(19MB, PDF)

Similar books

Book cover: Medicines By DesignMedicines By Design
- National Institutes of Health
This book about pharmacology explains how scientists unravel the many different ways medicines work in the body and how this information guides the hunt for drugs of the future. The book presents some of the latest research developments in the field.
(11862 views)
Book cover: Some Drugs and Herbal ProductsSome Drugs and Herbal Products
- International Agency for Research on Cancer
This volume provides an assessment of the carcinogenicity of 14 drugs and herbal products. The authors relied on epidemiological studies to evaluate the carcinogenic hazard to humans exposed to the drugs digoxin, pioglitazone and hydrochlorothiazide.
(8760 views)
Book cover: The Emerging Discipline of Quantitative Systems PharmacologyThe Emerging Discipline of Quantitative Systems Pharmacology
by - Frontiers Media S.A.
Quantitative Systems Pharmacology is still in its infancy, but has tremendous potential to change the way we approach biomedical research. QSP is really the integration of two disciplines: 'Systems Biology' and 'Quantitative Pharmacology'.
(6243 views)
Book cover: Improving and Accelerating Therapeutic Development for Nervous System DisordersImproving and Accelerating Therapeutic Development for Nervous System Disorders
- National Academies Press
The aim was to examine opportunities to accelerate drug development for nervous system drug discovery. Workshop participants discussed challenges in neuroscience research for enabling faster entry of potential treatments into first-in-human trials.
(8105 views)